Development and licensing agreement for ralinepag and etrasimodJune 14th, 2024
FiledJune 14th, 2024Arena Pharmaceuticals and Everest Medicines have entered into a development and commercialization partnership for ralinepag and etrasimod in mainland China, Taiwan, Hong Kong, Macau, and South Korea.